Syngene International share price

Balanced risk
  • 33%Low risk
  • 33%Moderate risk
  • 33%Balanced risk
  • 33%High risk
  • 33%Extreme risk
  • 625.00(-2.89%)
    June 19, 2025 15:29:48 PM IST
    • NSE
    • BSE
  • Vol : 417.99K (NSE + BSE)
    Last 20 day avg : 786.39 K

Syngene International is trading -2.89% lower at Rs 625.00 as compared to its last closing price. Syngene International has been trading in the price range of 653.00 & 625.00. Syngene International has given -24.92% in this year & -2.72% in the last 5 days. There are 9 analysts who have initiated coverage on Syngene International. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 183.30 Crores in its last quarter.Listed peers of Syngene International include Wockhardt (-1.87%), J B Chemicals And Pharmaceutical (-2.78%), Syngene International (-2.89%).The Mutual Fund holding in Syngene International was at 17.86% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Syngene International was at 19.47% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 19, 2025, 04:51 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.19
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    5.47
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    52.23
    Lower than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.91
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
625.00
Highest
653.00
52 week range
Lowest
598.55
Highest
960.00
Syngene International Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in March quarter by 11.03% from Rs 1018.00 crore to Rs 916.90 crore, year-on-year
    • financial-insightsThe company's profit declined by 2.81% year-on-year during the March quarter, dropping from Rs 188.60 crore to Rs 183.30 crore
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Syngene International Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 665.60
  • R2
  • 684.70
  • R3
  • 698.30
Pivot652.00
  • S1
  • 632.90
  • S2
  • 619.30
  • S3
  • 600.20
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Syngene International Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Wockhardt
Bullish
1,687.20-1.8727,413.46-6.43-30.00
J B Chemicals And Pharmaceutical
Neutral
1,671.10-2.7826,154.9041.567.830.710.19
Syngene International
Bearish
625.00-2.8925,183.7155.295.510.198.65
Piramal Pharma
Bearish
192.00-0.6225,455.68287.153.170.0740.78
Eris Lifesciences
Bullish
1,730.10-2.7223,570.7569.268.530.4162.42
Syngene International Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Syngene International is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 52.74%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 1.18 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 2.46 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    LIC MF Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 2.55
    • % of AUM 3.02
    Mirae Asset Focused Fund Regular Growth
    2/5
    • Amount Invested (Cr.) 223.16
    • % of AUM 2.82
    DSP Multicap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 57.65
    • % of AUM 2.55
    DSP Focused Fund Growth
    3/5
    • Amount Invested (Cr.) 63.83
    • % of AUM 2.48
    Nippon India Innovation Fund Regular Growth
    NA
    • Amount Invested (Cr.) 63.40
    • % of AUM 2.47
    Syngene International Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-04-23Audited Results & Final Dividend
    2025-01-23Quarterly Results
    2024-10-23Quarterly Results
    2024-07-24Quarterly Results
    2024-04-24Audited Results & Final Dividend
    About the company Syngene International
    • IndustryBiotechnology & Drugs
    • ISININE398R01022
    • BSE Code539268
    • NSE CodeSYNGENE
    Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The Company's services include discovery, development, manufacturing, SynVent Integrated Drug discovery, dedicated centers, and Center for Advanced Protein Studies (CAPS). Its discovery services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. It offers preclinical development, active pharmaceutical ingredient and drug product development for both small molecules and biologics. It has capabilities for current Good Manufacturing Practices (cGMP) manufacturing from benchtop volume to commercial scale. SynVent is its drug discovery platform for enabling fully integrated therapeutic drug discovery and development across small molecules, new modalities and biologics.
    • Management Info
    • Peter BainsChief Executive Officer, Managing Director, Additional Director
    • Deepak JainChief Financial Officer
    • Andrew WebsterChief Human Resources Officer
    • Kenneth BarrSenior Vice President - Discovery Services
    • Alex Del PrioreSenior Vice President - Manufacturing Services
    • Jayashree AiyarChief Scientific Officer
    • Pramuch GoelHead of Corporate Affairs
    • Caroline HempsteadHead of Corporate Affairs
    • Alok MehrotraChief Quality Officer
    Syngene International Share Price FAQs

    Syngene International is trading at 625.00 as on Thu Jun 19 2025 09:59:48. This is -2.89% lower as compared to its previous closing price of 643.60.

    The market capitalization of Syngene International is 25183.71 Cr as on Thu Jun 19 2025 09:59:48.

    The average broker rating on Syngene International is Buy. The breakup of analyst rating is given below -

    • 2 analysts have given a strong buy rating
    • 3 analysts have given a buy rating
    • 1 analysts have given a hold rating
    • 3 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Syngene International is 960.00 whereas the 52 wk low is 598.55

    Syngene International can be analyzed on the following key metrics -

    • TTM P/E: 58.75
    • Sector P/E: -
    • Dividend Yield: 0.19%
    • D/E ratio: 0.12

    Syngene International reported a net profit of 496.20 Cr in 2025.

    The Mutual Fund Shareholding was 17.86% at the end of 31 Mar 2025.